Acute myocardial infarction and renal dysfunction: A high-risk combination

Annals of Internal Medicine

Volumn 137, Issue 7, 2002, Pages 563-570

  Wright, R Scott ^a   Reeder, Guy S ^a   Herzog, Charles A ^a   Albright, Robert C ^a   Williams, Brent A ^a   Dvorak, David L ^a   Miller, Wayne L ^a   Murphy, Joseph G ^a   Kopecky, Stephen L ^a   Jaffe, Allan S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN DERIVATIVE; NITRATE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INDICATION; FEMALE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK MANAGEMENT; SURVIVAL RATE;

EID: 0036788828     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-7-200210010-00007     Document Type: Article

References (36)

1. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799-805. [PMID: 9738087]
2. Chertow GM, Normand SL, Silva LR, McNeil BJ. Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. Am J Kidney Dis. 2000;35:1044-51. [PMID: 10845815]
3. Causes of death. In: U.S. Renal Data System 1998 Annual Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 1998: 79-86.
4. U.S. Renal Data System 1997 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 1997:35-47. NIH publication no. 97-3176.
5. U.S. Renal Data System 1997 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 1997:C1-C41. NIH publication no. 97-3176.
6. U.S. Renal Data System 1997 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 1997:21-48. NIH publication no. 97-3176.
7. U.S. Renal Data System 1992 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 1992:61-82. NIH publication no. 92-3176.
8. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996;7:158-65. [PMID: 8808124]
9. Excerpts from United States Renal Data System 1998 Annual Data Report. Am J Kidney Dis. 1998;32(Suppl 1):S9-S141.
10. Herzog CA, Ma JZ, Collins AJ. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis. 2000;36:145-52. [PMID: 10873884]
11. Rubin TA, Thielen KA, Collins AJ, Herzog CA. Acute myocardial infarction in chronic dialysis patients [Abstract]. J Am Coll Cardiol. 1996;27(Suppl A):67A.
12. Kong TQ Dacanay S, Hsieh AA. Features of acute myocardial infarction in patients on chronic hemodialysis [Abstract]. Circulation. 1993; 88(Suppl I):1-49.
13. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis. 2001;37:1191-200. [PMID: 11382688]
14. Luke RG. Chronic renal failure - a vasculopathic state [Editorial]. N Engl J Med. 1998;339:841-3. [PMID: 9738095]
15. Ritz E, Amann K. Optimal haemoglobin during treatment with recombinant human erythropoietin. Nephrol Dial Transplant. 1998; 13(Suppl 2):16-22. [PMID: 9566486]
16. Becker BN, Himmelfarb J, Henrich WL, Hakim RM. Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol. 1997;8:475-86. [PMID: 9071717]
17. Venkatesan J, Henrich WL. Anemia, hypertension, and myocardial dysfunction in end-stage renal disease. Semin Nephrol. 1997;17:257-69. [PMID: 9241712]
18. Orth SR, Ritz E, Schrier RW. The renal risks of smoking. Kidney Int. 1997;51:1669-77. [PMID: 9186854]
19. Jungers P, Massy ZA, Khoa TN, Fumeron C, Labrunie M, Lacour B, et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant. 1997;12:2597-602. [PMID: 9430858]
20. Mourad JJ, Girerd X, Boutouyrie P, Laurent S, Safar M, London G. Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension. 1997;30:1425-30. [PMID: 9403563]
21. Herzog CA, Ma J, Collins AJ. Outcome of dialysis patients receiving thrombolytic therapy for acute myocardial infarction (AMI) in the United States [Abstract]. Circulation. 1997;96(Suppl I):I-202.
22. Medication use among dialysis patients in the DMMS. In: U.S. Renal Data System 1998 Annual Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 1998:51-60.
23. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J. 1984;108: 150-8. [PMID: 6731265]
24. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457-64. [PMID: 6059183]
25. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41. [PMID: 1244564]
26. Kimmel PJ. Management of the patient with chronic renal failure. In: Greenberg A, ed. Primer on Kidney Diseases. 2nd ed. San Diego: Academic Pr; 1998.
27. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet. 1994;343:311-22. [PMID: 7905143]
28. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med. 1993;329: 1615-22. [PMID: 8232430]
29. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51. [PMID: 3594774]
30. Migrino RQ, Young JB, Ellis SG, White HD, Lundergan CF, Miller DP, et al. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. Circulation. 1997;96:116-21. [PMID: 9236425]
31. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet. 1986;2:57-66. [PMID: 2873379]
32. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group. Eur Heart J. 1985;6:199-226. [PMID: 2863148]
33. Long-term prognosis after early intervention with metoprolol in suspected acute myocardial infarction: experiences from the MIAMI Trial. The MIAMI Trial Research Group. J Intern Med. 1991;230:233-7. [PMID: 1895045]
34. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801-7. [PMID: 7010157]
35. Roberts R, Rogers WJ, Mueller HS, Lambrew CT, Diver DJ, Smith HC, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation. 1991;83:422-37. [PMID: 1671346]
36. Hennekens CH, Albert CM, Gocifried SL, Gaziano JM, Buring JE. Adjunctive drug therapy of acute myocardial infarction-evidence from clinical trials. N Engl J Med. 1996;335:1660-7. [PMID: 8929364]